Monday, August 31, 2026

Tesla Stock Was 3.35% Up On Wednesday

ViaNews Editorial Team

November 25, 2020

Tesla Stock Was 3.35% Up On Wednesday
According to today's article on Bloomberg Quint, "Nikola, Tesla Shares Fall as EV Rally Frenzy Comes to a Halt." According to today's article on MarketWatch, "Tesla issues recall of 9,000-plus Model X and Model Y vehicles." The Nasdaq Stock Market ended the session with Tesla rising 3.35% to $574.00 on Wednesday while the The Nasdaq Stock Market jumped 0.48% to $12,094.40. According to yesterday's article on Bloomberg Quint, "Musk Hints Again at Longer-Range Teslas and Hatchback for Europe." According to yesterday's article on Bloomberg Quint, "Tesla Nears Half a Trillion Mark After Soaring 525% This Year." Tesla today's close was $574.00, 0.05% below its 52-week high of $573.70. Tesla's sales growth is 35.3% for the ongoing quarter and 60% for the next. The company's growth estimates for the present quarter and the next is 112.2% and 265.2%, respectively. Year-on-year quarterly revenue growth grew by 39.2%, now sitting on 28.18B for the twelve trailing months. Tesla's stock is valued at $574.00 at 16:43 EST, above its 52-week high of $573.70. Tesla's value is way higher than its 50-day moving average of $435.96 and way higher than its 200-day moving average of $332.14. Tesla-heavy etfs ride along as company gets a price upgrade. According to MarketWatch on Mon Nov 23, "Exchovere-traded funds with heavy exposure to Tesla Inc."
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com